16-89775771-G-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000135.4(FANCA):c.1871C>G(p.Ala624Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,612,888 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A624V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | c.1871C>G | p.Ala624Gly | missense_variant | Exon 21 of 43 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000441 AC: 11AN: 249394 AF XY: 0.0000371 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460592Hom.: 1 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726444 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000230 AC: 35AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74464 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The FANCA c.1871C>G (p.Ala624Gly) variant has not been reported in individuals with FANCA-related conditions in the published literature. The frequency of this variant in the general population, 0.00073 (18/24760 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant.
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Fanconi anemia Uncertain:1Benign:1
Inborn genetic diseases Uncertain:1
The p.A624G variant (also known as c.1871C>G), located in coding exon 21 of the FANCA gene, results from a C to G substitution at nucleotide position 1871. The alanine at codon 624 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Fanconi anemia complementation group A Uncertain:1
FANCA-related disorder Uncertain:1
The FANCA c.1871C>G variant is predicted to result in the amino acid substitution p.Ala624Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.073% of alleles in individuals of African descent in gnomAD, which is more common than expected for an undocumented cause of disease. Although we suspect that this variant may be benign, at this time, the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at